BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim JH, Youn T, Choi JG, Jeong SH, Jung HY, Kim YS, Chung IW. Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia. Psychiatry Investig 2018;15:829-35. [PMID: 30086612 DOI: 10.30773/pi.2018.05.15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Ong M, Patterson E, Stewart L, Pierce D, Smith JR. Morbidity Due to Disparity in Pediatric Electroconvulsive Therapy. Journal of the American Academy of Child & Adolescent Psychiatry 2022. [DOI: 10.1016/j.jaac.2022.07.850] [Reference Citation Analysis]
2 Iasevoli F, D'Ambrosio L, Ciccarelli M, Barone A, Gaudieri V, Cocozza S, Pontillo G, Brunetti A, Cuocolo A, de Bartolomeis A, Pappatà S. Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study. Schizophr Bull 2022:sbac147. [PMID: 36268829 DOI: 10.1093/schbul/sbac147] [Reference Citation Analysis]
3 Ainsworth NJ, Avina-Galindo AM, White RF, Zhan D, Gregory EC, Honer WG, Vila-Rodriguez F. Impact of medications, mood state, and electrode placement on ECT outcomes in treatment-refractory psychosis. Brain Stimul 2022:S1935-861X(22)00190-5. [PMID: 36028155 DOI: 10.1016/j.brs.2022.08.012] [Reference Citation Analysis]
4 Oh HS, Lee BJ, Lee YS, Jang O, Nakagami Y, Inada T, Kato TA, Kanba S, Chong M, Lin S, Si T, Xiang Y, Avasthi A, Grover S, Kallivayalil RA, Pariwatcharakul P, Chee KY, Tanra AJ, Rabbani G, Javed A, Kathiarachchi S, Myint WA, Cuong TV, Wang Y, Sim K, Sartorius N, Tan C, Shinfuku N, Park YC, Park S. Machine Learning Algorithm-Based Prediction Model for the Augmented Use of Clozapine with Electroconvulsive Therapy in Patients with Schizophrenia. JPM 2022;12:969. [DOI: 10.3390/jpm12060969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bağcaz A, Başar K. Mirror-Image Comparison of Maintenance Electroconvulsive Treatment Effectiveness in Affective and Psychotic Disorders. J ECT 2022. [PMID: 35700971 DOI: 10.1097/YCT.0000000000000864] [Reference Citation Analysis]
6 Tan X, Martin D, Lee J, Tor PC. The Impact of Electroconvulsive Therapy on Negative Symptoms in Schizophrenia and Their Association with Clinical Outcomes. Brain Sciences 2022;12:545. [DOI: 10.3390/brainsci12050545] [Reference Citation Analysis]
7 Cheng J, Ren Y, Gu Q, He Y, Wang Z. QEEG Biomarkers for ECT Treatment Response in Schizophrenia. Clin EEG Neurosci 2021;:15500594211058260. [PMID: 34792399 DOI: 10.1177/15500594211058260] [Reference Citation Analysis]
8 Shan X, Zhang H, Dong Z, Chen J, Liu F, Zhao J, Zhang H, Guo W. Increased subcortical region volume induced by electroconvulsive therapy in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2021. [PMID: 34275006 DOI: 10.1007/s00406-021-01303-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zierhut MM, Bernard RM, Turner E, Mohamad S, Hahn E, Bajbouj M. Electroconvulsive therapy for negative symptoms in schizophrenia: a literature review from 2000 to 2021. Curr Psychol. [DOI: 10.1007/s12144-021-01989-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Chung IW, Kim HS, Kim JH, Jang JH, Kim YS. Resolution of Persistent Auditory Verbal Hallucinations after Long-term Electroconvulsive Therapy Maintenance: A Case Report of a Patient with Clozapine-resistant Schizophrenia. Clin Psychopharmacol Neurosci 2021;19:170-173. [DOI: 10.9758/cpn.2021.19.1.170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Youn T, Jeong SH, Kim YS, Chung IW. Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine. Psychiatry Research 2019;273:759-66. [DOI: 10.1016/j.psychres.2019.02.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Grover S, Sahoo S. Treatment of Clozapine Nonresponders. Curr Treat Options Psych 2019;6:32-63. [DOI: 10.1007/s40501-019-0166-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]